OpenEvidence, a Cambridge, MA-based medical search and AI software supplier, raised $210M in Sequence B funding.
Backers included Sequoia Capital, Coatue, Conviction, and Thrive.
The corporate intends to make use of the funds to broaden strategic content material partnerships that improve its library of superior medical data.
Based by Daniel Nadler, and Zachary Ziegler, OpenEvidence is a supplier of a scientific resolution help platform in the US. It’s actively used throughout greater than 10,000 hospitals and medical facilities nationwide and by over 40% of physicians in the US who log in each day to make high-stakes scientific selections on the level of care.
OpenEvidence has additionally introduced key strategic content material partnerships with the American Medical Affiliation (JAMA) and The New England Journal of Medication in order that full-text content material and multimedia from the worldwide gold requirements of medical data are used to tell solutions in its solution0.
The corporate has raised greater than $300M since its founding.
FinsMEs
15/07/2025
